In conclusion, PD-L1 expression using a 22C3 assay at clinically relevant cutoff could be predicted in higher N stage, histological solid pattern, wild-type EGFR, and ALK positive in lung adenocarcinoma. Here, CD274 is linked to lung adenocarcinoma.